# Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer

> **NCT00014066** · PHASE1 · COMPLETED · sponsor: **Roswell Park Cancer Institute**

## Conditions studied

- Lung Cancer

## Interventions

- **DRUG:** hematoporphyrin derivative
- **RADIATION:** brachytherapy

## Key facts

- **NCT ID:** NCT00014066
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-03
- **Primary completion:** 2004-02
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2013-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00014066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00014066, "Photodynamic Therapy Plus Brachytherapy in Treating Patients With Lung Cancer". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00014066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*